buff.ly
Blood tests are currently one-size-fits-all − machine learning can pinpoint what’s truly ‘normal’ for each patient
A narrower, more personalized ‘normal range’ could help doctors better diagnose and treat disease in individual patients.
#PersonalizedMedicine is an active hashtag on Bluesky. In the last 30 days, 12 people shared 21 posts with it — around 1 a day. Activity is down 75% versus the previous week, peaking on Jul 15 with 3 posts.
Tags most often used together with #PersonalizedMedicine.
buff.ly
Blood tests are currently one-size-fits-all − machine learning can pinpoint what’s truly ‘normal’ for each patient
A narrower, more personalized ‘normal range’ could help doctors better diagnose and treat disease in individual patients.
www.riken.jp
BRCA gene mutations now implicated in thyroid, bladder, skin, and head and neck cancer
bit.ly
Canada launches $200M genomics data initiative to drive precision health and economic growth - GenomeCanada
The CPHI will build Canada’s largest-ever collection of human genomic data—more than 100,000 genomes representing the diversity of Canada’s population.
oncodaily.com
Wafik S. El-Deiry: Worldwide Innovative Network Consortium in Personalized Cancer Medicine - OncoDaily
Wafik S. El-Deiry: Worldwide Innovative Network Consortium in Personalized Cancer Medicine / Brown University, cancer, Cancer Medicine, fight against cancer,
www.news-medical.net
Mapping human biology: Human Cell Atlas leads a new era in precision medicine
The Human Cell Atlas project maps human cells to understand biology, address global health disparities, and advance personalized medicine through ethical and inclusive research practices.
www.news-medical.net
Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies
Researchers used stem-cell derived organoids from Crohn's disease patients to identify two molecular subtypes, paving the way for personalized treatments targeting specific disease characteristics.
rdcu.be
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling
Nature Cancer - Trumpp and colleagues develop a method to obtain long-term circulating tumor cell-derived organoids from individuals with metastatic breast cancer and identify the neuregulin...
www.news-medical.net
Essential Baseline Lab Tests for Preventive Health Assessment
This encyclopedic article outlines evidence-based laboratory tests that are most useful for establishing individualized health baselines while avoiding unnecessary screening. It emphasizes biological ...
www.xiahepublishing.com
Artificial Intelligence for Personalized Critical Care
Critical care medicine requires rapid, high-stakes decisions informed by dynamic and complex streams of patient data. Traditional predictive models have shown value in forecasting deterioration and identifying subphenotypes. However, this leaves a critical gap between anticipating adverse outcomes and guiding therapeutic interventions. Achieving true personalization demands moving beyond generalized protocols toward individualized strategies that account for patient heterogeneity and consequences of alternative clinical actions. Emerging methods in prescriptive artificial intelligence, particularly causal machine learning (causal ML) and reinforcement learning (RL), are beginning to bridge this gap. Causal ML enables estimation of individualized treatment effects by addressing confounding and enabling counterfactual reasoning, allowing clinicians to ask whether a specific intervention is likely to help or harm a given patient. RL can generate adaptive treatment policies that evolve with patient state. The objective of this review is to examine how critical care can progress from generalized prediction to true personalization through the development of prescriptive artificial intelligence. The review contributes by (1) surveying the achievements and limitations of current predictive models, (2) detailing how causal ML and RL can generate individualized treatment effects and sequential decision strategies, (3) identifying the major translational, technical, clinical, ethical, and regulatory barriers to implementation, and (4) outlining future pathways such as digital twins and clinician in the loop systems that may enable safe and actionable personalized decision support at the bedside.
nile1.com
Health Tech to Outpace AI and Robotics in Global Impact by 2030, IEEE Study Finds
That assessment comes from the Institute of Electrical and Electronics Engineers (IEEE), the world's largest professional technical organization. In its newly
www.ishlt.org
JHLT Call for Papers: Themed Issue on Personalized Medicine in Thoracic Transplantation
JHLT will release a special issue in the first quarter of 2027 dedicated to manuscripts focused on precision medicine across the patient journey. Submissions for this issue are now being accepted unti...
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.